Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations

Abstract Background Nonadherence to antipsychotic treatment increases the likelihood of relapse and progressive symptomatology in patients with schizophrenia. Atypical long-acting injectables, including paliperidone palmitate (PP), may increase adherence and improve symptoms. This study compared and...

Full description

Bibliographic Details
Main Authors: Jeffrey P. Anderson, Zeynep Icten, Veronica Alas, Carmela Benson, Kruti Joshi
Format: Article
Language:English
Published: BMC 2017-10-01
Series:BMC Psychiatry
Subjects:
Paliperidone palmitate
Oral antipsychotics
Schizophrenia
Adherence
Remission
Community behavioral health organization
Online Access:http://link.springer.com/article/10.1186/s12888-017-1507-8

Similar Items

Similar Items